Stemline Therapeutic (STML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,678 | -28,830 | -21,898 | -15,013 | -9,000 |
| Depreciation Amortization | 49 | 403 | 266 | 214 | 38 |
| Other Working Capital | -924 | -1,719 | -1,072 | -2,091 | -921 |
| Other Operating Activity | 1,241 | 4,433 | 3,308 | 2,022 | 1,043 |
| Operating Cash Flow | $-7,312 | $-25,714 | $-19,396 | $-14,868 | $-8,840 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -17,524 | -16,247 | 3,583 | -8,241 | -11,196 |
| Sale Of Investment | N/A | 22,632 | N/A | N/A | N/A |
| Investing Cash Flow | $-17,524 | $6,385 | $3,583 | $-8,241 | $-11,196 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 64,461 | 135 | 102 | 69 | 37 |
| Financing Cash Flow | $64,461 | $135 | $102 | $69 | $37 |
| Beginning Cash Position | 25,007 | 44,200 | 44,200 | 44,200 | 44,200 |
| End Cash Position | 64,633 | 25,007 | 28,489 | 21,160 | 24,201 |
| Net Cash Flow | $39,626 | $-19,193 | $-15,711 | $-23,040 | $-19,999 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,312 | -25,714 | -19,396 | -14,868 | -8,840 |
| Free Cash Flow | -7,312 | -25,714 | -19,396 | -14,868 | -8,840 |